Nutriband Inc. (NASDAQ:NTRB - Get Free Report)'s stock price traded up 1.4% on Monday . The company traded as high as $5.20 and last traded at $5.12. 6,122 shares were traded during trading, a decline of 92% from the average session volume of 74,903 shares. The stock had previously closed at $5.05.
Wall Street Analysts Forecast Growth
Separately, Noble Financial started coverage on shares of Nutriband in a report on Wednesday, January 22nd. They issued an "outperform" rating and a $13.00 price target for the company.
View Our Latest Research Report on NTRB
Nutriband Stock Performance
The stock's 50-day moving average price is $6.08 and its 200-day moving average price is $5.75. The company has a market capitalization of $59.08 million, a price-to-earnings ratio of -7.49 and a beta of 1.19. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.83 and a current ratio of 4.96.
Hedge Funds Weigh In On Nutriband
A hedge fund recently bought a new stake in Nutriband stock. Haven Private LLC purchased a new stake in Nutriband Inc. (NASDAQ:NTRB - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 11,561 shares of the company's stock, valued at approximately $54,000. Haven Private LLC owned approximately 0.10% of Nutriband as of its most recent SEC filing. Institutional investors and hedge funds own 19.70% of the company's stock.
About Nutriband
(
Get Free Report)
Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.
Featured Articles
Before you consider Nutriband, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutriband wasn't on the list.
While Nutriband currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
